Organ culture as a tool to identify early mechanisms of serotonergic valve disease

Journal of Heart Valve Disease

Volumn 19, Issue 5, 2010, Pages 626-635

  Barzilla, Janet E ^a   Acevedo, Frances E ^b   Grande Allen, K Jane ^a  

^a Rice University   (United States)

^b UNIVERSITY OF HOUSTON DOWNTOWN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; DECORIN; GELATINASE B; HEAT SHOCK PROTEIN 47; NORFENFLURAMINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SEROTONIN; SEROTONIN 2B RECEPTOR; VERSICAN;

ANIMAL TISSUE; ARTICLE; BIOREACTOR; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MITRAL VALVE; NONHUMAN; ORGAN CULTURE; PATHOGENESIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VALVULAR HEART DISEASE;

ANIMALS; BIOREACTORS; DECORIN; DISEASE MODELS, ANIMAL; HEART VALVE DISEASES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MITRAL VALVE; NORFENFLURAMINE; ORGAN CULTURE TECHNIQUES; SEROTONIN; SEROTONIN AGENTS; SWINE; VERSICANS;

EID: 78149277717     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Di Luzio S, Rigolin VH. Carcinoid heart disease. Curr Treat Options Cardiovasc Med 2000;2:399-406
2. Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV. Surgical pathology of carcinoid heart disease: A study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002;77:139-147
3. Tanaka M, Matsubara O, Takemura T, et al. Cardiovascular lesion of carcinoid syndrome. An autopsy case of bronchial carcinoid. Acta Pathol Jpn 1984;34:201-213
4. Biswas SS, Donovan CL, Forbess JM, Royal SH, Landolfo KP. Valve replacement for appetite suppressant-induced valvular heart disease. Ann Thorac Surg 1999;67:1819-1822
5. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-588
6. Volmar KE, Hutchins GM. Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents. Arch Pathol Lab Med 2001;125:1555-1561
7. Van Camp G, Flamez A, Cosyns B, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004;363:1179-1183
8. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356:39-46
9. Setola V, Hufeisen SJ, Grande-Allen KJ, et al. 3,4- Methylenedioxymethamphetamine (MDMA, 'Ecstasy') induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 2003;63:1223-1229
10. Jian B, Xu J, Connolly J, et al. Serotonin mechanisms in heart valve disease I: Serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 2002;161:2111-2121
11. Xu J, Jian B, Chu R, et al. Serotonin mechanisms in heart valve disease II: The 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 2002;161:2209-2218
12. Roth BL. Drugs and valvular heart disease. N Engl J Med 2007;356:6-9
13. Grande-Allen KJ, Osman N, Ballinger ML, Dadlani H, Marasco S, Little PJ. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease. Cardiovasc Res 2007;76:19-28
14. Nigro J, Ballinger ML, Dilley RJ, Jennings GL, Wight TN, Little PJ. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding. Diabetologia 2004;47:2105-2113
15. Fitzgerald LW, Burn TC, Brown BS, et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 2000;57:75-81
16. Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH. Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis 2000;9:454-458
17. Rajamannan NM, Caplice N, Anthikad F, et al. Cell proliferation in carcinoid valve disease: A mechanism for serotonin effects. J Heart Valve Dis 2001;10:827-831
18. Rothman RB, Baumann MH, Savage JE, et al. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000;102:2836-2841
19. Setola V, Dukat M, Glennon RA, Roth BL. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. Mol Pharmacol 2005;68:20-33
20. Roy A, Brand NJ, Yacoub MH. Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves. J Heart Valve Dis 2000;9:256-60; discussion 260-261
21. Mekontso-Dessap A, Brouri F, Pascal O, et al. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 2006;113:81-89
22. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 1989;264:4571-4576
23. O'Malley FP, Saad Z, Kerkvliet N, et al. The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer. Hum Pathol 1996;27:955-963
24. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001;104:2525-2532
25. Gupta V, Barzilla JE, Mendez JS, et al. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc Pathol 2009;18:191-197
26. McDonald PC, Wilson JE, Gao M, et al. Quantitative analysis of human heart valves: Does anorexigen exposure produce a distinctive morphological lesion? Cardiovasc Pathol 2002;11:251-262
27. Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fandrich F. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. J Biol Chem 2005;280:2644-2652
28. Grande-Allen KJ, Calabro A, Gupta V, Wight TN, Hascall VC, Vesely I. Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordae: Association with regions of tensile and compressive loading. Glycobiology 2004;14:621-633
29. Zolkowska D, Baumann MH, Rothman RB. Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels. J Pharmacol Exp Ther 2008;324:791-797